Skip to main content
$61.87 $0.92 (1.5%)

04:00 PM EDT on 04/14/21

Simulations Plus, Inc. (NASDAQ:SLP)

CAPS Rating: 4 out of 5

The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.

Current Price $61.87 Mkt Cap $1.2B
Open $61.07 P/E Ratio 107.04
Prev. Close $60.95 Div. (Yield) $0.24 (0.4%)
Daily Range $61.07 - $63.32 Volume 206,483
52-Wk Range $36.04 - $90.92 Avg. Daily Vol. 208,573

Caps

How do you think NASDAQ:SLP will perform against the market?

Add Stock to CAPS Watchlist

All Players

165 Outperform
6 Underperform
 

All-Star Players

38 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SLP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

oohaeagle (93.40)
Submitted February 07, 2011

I really like the chart for SLP and the other metrics. Good insider ownership. Buying back stock. With drug companies looking to reduce costs anywhere they can, SLP can help. Also a potential buy out candidate as they gain more share and get the… More

doublet83 (84.05)
Submitted September 25, 2007

Market overestimating the addressable market of their product. Valuation can only be justified if historical growth rates are sustained for a significant period of time, but these growth rates are clearly unsustainble.

NASDAQ:SLP VS S&P 500 (SPY)

Fools bullish on NASDAQ:SLP are also bullish on:

Fools bearish on NASDAQ:SLP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SLP.

Recs

0
Member Avatar TMFacarchidi (< 20) Submitted: 2/12/2021 3:28:59 PM : Outperform Start Price: $84.98 NASDAQ:SLP Score: -32.21

Links into the biotechnology gold rush without being exposed directly to the risk of drug development. It also stands to benefit from upcoming improvements in computing technology.

Recs

0
Member Avatar frederickdouglas (67.38) Submitted: 12/28/2020 8:33:42 PM : Outperform Start Price: $73.16 NASDAQ:SLP Score: -25.50

Just tracking

Recs

0
Member Avatar cutchemist42 (80.79) Submitted: 9/10/2020 11:18:57 AM : Outperform Start Price: $68.27 NASDAQ:SLP Score: -30.22

Feroldi....similar to SDGR but more drug development and high margin consulting

Leaderboard

Find the members with the highest scoring picks in SLP.

Score Leader

eversuhoshin

eversuhoshin (69.82) Score: +2,895.55

The Score Leader is the player with the highest score across all their picks in SLP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
eversuhoshin 69.82 7/9/2010 Outperform 5Y $1.89 +3,179.62% +284.07% +2,895.55 0 Comment
marc021248 55.66 7/20/2010 Outperform 5Y $1.96 +3,059.86% +286.52% +2,773.34 0 Comment
alley11 < 20 7/8/2010 Outperform 5Y $1.98 +3,021.91% +284.53% +2,737.38 0 Comment
browns31 < 20 7/14/2010 Outperform 1Y $1.99 +3,009.20% +276.72% +2,732.48 1 Comment
Southoftheborder 56.53 12/14/2010 12/16/2017 Outperform 5Y $2.09 +2,866.53% +230.77% +2,635.76 0 Comment
Pepe150 < 20 1/12/2011 Outperform 1Y $2.19 +2,726.53% +220.92% +2,505.62 1 Comment
stratisticalarb 25.42 5/6/2011 Outperform 1Y $2.34 +2,543.79% +206.48% +2,337.31 0 Comment
pureoncharts 59.40 1/18/2011 Outperform 3W $2.33 +2,553.54% +218.51% +2,335.03 0 Comment
kitenio 95.62 11/3/2010 Outperform 1Y $2.44 +2,431.92% +244.21% +2,187.71 0 Comment
anguijm 71.69 4/25/2011 Outperform 5Y $2.55 +2,321.62% +207.79% +2,113.83 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SLP.